Telemedicine Company Equity Stake For Sale in New Delhi, India
Doctor-led, AI-enabled preventive chronic care platform providing continuous patient management via monthly subscription, seeks investment.
Premium Plan
| Established | 5-10 year(s) |
| Employees | 10 - 50 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 160 thousand |
| Run Rate Sales | USD 160 thousand |
| EBITDA Margin | 0 - 10 % |
| Industries | Telemedicine + 1 more |
| Locations | New Delhi |
| Local Time | 2:51 PM Asia / Kolkata |
| Listed By | Advisor / Business Broker |
| Status | Active |
Partial Stake Sale
USD
214 thousand
for
25.0%
stake
(Native Currency: INR 20,000,000)
Reason: The funds will be used for:
- Scaling the AI-enabled care platform.
- Expanding chronic care progr...
View More
Includes physical assets worth
USD
37.4 thousand
Name, Phone, Email
Not disclosed
Business Name
Not disclosed
User Verification
Documents
Pitch Deck
(3.1 MB)
Business Overview
- Doctor-led platform based in New Delhi, focusing on preventive chronic care and leveraging AI for improved patient management.
- Since August last year, the business has enrolled 758 paying subscribers for their healthcare needs.
- The subscription-based model ranges from ₹2,000 to ₹6,000 per patient per month, has generated steady monthly recurring chronic care revenue of approximately ₹12 lakhs and contributed to a total group revenue of over ₹1.49 crore in the last financial year, with a group PAT of ₹2.98 lakh.
- About 60% of bookings come from repeat revenue, reflecting high patient retention, and clinical adherence rates remain strong at over 80%.
- The platform's integrated ecosystem encompasses diagnostics, pharmacy services, and a comprehensive care platform, providing end-to-end support for patients.
- The business is backed by experienced doctor-led founders with deep healthcare domain expertise and is fully registered with the MCA.
- Since August last year, the business has enrolled 758 paying subscribers for their healthcare needs.
- The subscription-based model ranges from ₹2,000 to ₹6,000 per patient per month, has generated steady monthly recurring chronic care revenue of approximately ₹12 lakhs and contributed to a total group revenue of over ₹1.49 crore in the last financial year, with a group PAT of ₹2.98 lakh.
- About 60% of bookings come from repeat revenue, reflecting high patient retention, and clinical adherence rates remain strong at over 80%.
- The platform's integrated ecosystem encompasses diagnostics, pharmacy services, and a comprehensive care platform, providing end-to-end support for patients.
- The business is backed by experienced doctor-led founders with deep healthcare domain expertise and is fully registered with the MCA.
Products & Services Overview
Products & services:- Preventive & chronic care platform.
- Mobile application.
- Diagnostics labs.
- Pharmacy.
Who uses them:
- Individuals managing chronic diseases such as diabetes, hypertension, thyroid disorders, PCOS, and cardiometabolic risk.
- Corporate employee health programs.
How they use them:
Patients enroll in a monthly subscription program where they receive:
- Doctor supervision.
- Remote health monitoring.
- Diagnostic tests.
- Pharmacy delivery.
- Lifestyle and clinical interventions.
AI monitors patient data continuously and alerts doctors to early clinical action.
Assets Overview
Tangible assets:- Diagnostics lab equipment.
- Pharmacy inventory and distribution infrastructure.
- Office infrastructure and IT systems.
Intangible assets:
- Digital platform and mobile app.
- AI-driven care management system.
- Proprietary patient data and care protocols.
- Brand and healthcare ecosystem partnerships.
Facilities Overview
The company operates through:- Diagnostics labs.
- Pharmacy distribution operations.
- Digital health platform.
- Facilities include diagnostic infrastructure, pharmacy distribution operations and office operations supporting the platform.
Has a rented office space in New Delhi.
Capitalization Overview
The company is bootstrapped by the founders.Shareholding.
- Founder 1 - 50%
- Founder 2 - 50%
Borrowings exist primarily within the pharmacy business unit as part of working capital operations.
Recent Activity
-
an hour agoManaging Director, Food & Beverage Exporter, Bengaluru, Individual Investor / Buyer connected with the Business
-
an hour agoAudit Senior, Accounting Firm, Gurugram, Individual Investor / Buyer connected with the Business
-
2 days, 1 hour agoFounder, Internet, Delhi, Individual Investor / Buyer connected with the Business
Tags:
Telemedicine Company Investment Opportunity in New Delhi, India
·Telemedicine Company Equity Stake For Sale in New Delhi, India
·Mobile App Investment Opportunity in New Delhi, India
·Mobile App Equity Stake For Sale in New Delhi, India
·Phone App Investment Opportunity in New Delhi, India
·Phone App Equity Stake For Sale in New Delhi, India
·Invest in Telemedicine Company in New Delhi, India
·Telemedicine Company Investment Opportunity
·Investment Opportunity in New Delhi, India
·Invest in Mobile App in New Delhi, India
·Invest in Phone App in New Delhi, India
·Mobile App Investment Opportunity
·Phone App Investment Opportunity
·Invest in Telemedicine Company
·Invest in New Delhi, India
·Invest in Mobile App
·Invest in Phone App
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
8 Investors contacted this Business this week.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 66,000+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses